ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2572

Rab4a Control over Glycolytic Metabolism and T-Cell Lineage Specification Protects from Intra-Alveolar Hemorrhage in Mouse Model of SLE

Nick Huang1, Zachary Oaks2, Sarah Blair2, Thomas Winans2, Zhi-Wei Lai1, Katalin Banki3 and Andras Perl1, 1Medicine, SUNY Upstate Medical University, Syracuse, NY, 2SUNY Upstate Medical University, Syracuse, NY, 3Clinical Pathology, SUNY Upstate Medical University, Syracuse, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Metabolism, pathogenesis and regulatory cells, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Lupus Erythematosus – Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Systemic lupus erythematosus (SLE) is a potentially fatal autoimmune disease that involves all organs of the body. Without a known cure, a detailed understanding of pathogenesis is vital for development of new treatments. The polymorphic Rab4a locus has been associated with genetic susceptibility and protection from lung disease in patients with SLE (Arthritis Rheum 58: 532-540). Rab4a is overexpressed in T cells of patients and mice with SLE (J Immunol 182: 2063-73). To determine the role of Rab4a in pathogenesis, its impact on intra-alveolar hemorrhage (IAH), a fatal complication of pulmonary involvement, was investigated in Rab4A-KOCD4Cre (KO) mice lacking expression of Rab4a in T cells relative to wild-type (WT) controls. Additionally, the role of Rab4a in T-cell lineage specification and underlying metabolic pathways was investigated in mice and human T-cell lines with modulated Rab4a activity.

Methods:

Mice matched for age and gender were injected intraperitoneally with 0.5 ml per 20 g of body weight of pristane and evaluated for pulmonary capillaritis. 14 days after injection, spleen and lung tissues were harvested and examined for lineage specification within the adaptive and innate arms of the immune system by flow cytometry. CD4+CD25+ T cells were analyzed for regulatory T cell (Treg) function. Metabolic studies were completed using the Seahorse Metabolic Flux Analyzer.

Results:

Pulmonary vasculitis scores were increased in Rab4A-KOCD4Cre mice relative to WT controls, which was underlain by 5.7-fold (p=0.0003) expansion of Gr-1+ neutrophils in the lung of KO mice. Among infiltrating T lymphocytes, CD4+ cells were increased by 42% (p=0.0018) and CD8+ cells were depleted by 45% (p=0.0037). TH1 cells, CD4+CD25+ and CD8+CD25+ Tregs were expanded by 9.4-fold (p=0.002), 4.6 fold (p=0.0009) and 2.6-fold (p=0.017), respectively. mTORC1 activities were decreased in all CD4+ T cells and CD4+CD25+ Tregs of the KO mice by 45% (p=0.01) and 29% (p=0.027), respectively. CD4+CD25+ FoxP3+/Akt– Tregs were depleted by 45% (p=0.02). The suppressor activity of CD4+CD25+ Tregs was diminished 3.8-fold (±0.05, p=0.04) in KO mice. Glycolysis in CD4+ TH1 cells and Tregs of Rab4A-KOCD4Cre mice was diminished by 27% (p=0.02) and 35% (p=0.029). Along this line, glycolysis was also reduced by 22% in Jurkat T cells overexpressing dominant negative Rab4aS27N (p=0.004). In contrast, overexpression of wild-type Rab4a enhanced glycolysis in Jurkat cells by 72% (p=5.41E-06). 1 mg/kg of rapamycin, which blocked nephritis in lupus-prone mice (Ann Rheum Dis 73: 1888-97), failed to prevent pristane-induced IAH.

Conclusion:

Rab4a controls metabolic fitness and mTORC1-dependent expansion and function of Tregs, and thus it protects against IAH in a mouse model of SLE.


Disclosure: N. Huang, None; Z. Oaks, None; S. Blair, None; T. Winans, None; Z. W. Lai, None; K. Banki, None; A. Perl, Pfizer, 2.

To cite this abstract in AMA style:

Huang N, Oaks Z, Blair S, Winans T, Lai ZW, Banki K, Perl A. Rab4a Control over Glycolytic Metabolism and T-Cell Lineage Specification Protects from Intra-Alveolar Hemorrhage in Mouse Model of SLE [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/rab4a-control-over-glycolytic-metabolism-and-t-cell-lineage-specification-protects-from-intra-alveolar-hemorrhage-in-mouse-model-of-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rab4a-control-over-glycolytic-metabolism-and-t-cell-lineage-specification-protects-from-intra-alveolar-hemorrhage-in-mouse-model-of-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology